Effects of a 12-week yogic breathing intervention on metabolic syndrome severity and cardiovascular risk factors: A randomized controlled trial
Complementary Therapies in Medicine · 2026-12 · 103 · 103447
DOI: 10.1016/j.ctim.2026.103447 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Complementary Therapies in Medicine, 2026-12. Verfasst von Dilasha Sethi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Yoga & Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, 560105, India. Electronic address: dilashasethi…. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
AIMS: To evaluate the effects of Yogic breathing (Sudarshan Kriya Yoga [SKY]) on conventional and atypical cardiovascular risk factors in adults with metabolic syndrome (MetS). METHODS: In this 12-week, two-arm randomized controlled trial, 72 adults (30-60 years) with MetS were randomized (1:1) to SKY plus standard care or waitlisted standard care control group. Conventional and atypical cardiovascular risk factors, spanning behavioral, biological, inflammatory, oxidative, and autonomic markers, were assessed at baseline and 3 months. Between-group effects were evaluated by ANCOVA (adjusted for baseline values and medication use) using per-protocol (PP) and intention-to-treat (ITT; last observation carried forward) analyses. RESULTS: 64 participants completed follow-up (SKY, n = 34; control, n = 30). Improvements consistent across PP and ITT occurred in waist circumference (p = 0.025/0.035), MetS severity score (MetSSS) (p = 0.020/0.014), and heart rate variability (HRV) low-frequency (LF) and high-frequency (HF) power (p = 0.035/0.010). Self-regulation of eating behavior, systolic blood pressure (SBP), and LF/HF ratio were significant only under ITT (p = 0.0498, 0.035, 0.041), not PP (p = 0.146, 0.056, 0.118). No significant between-group differences were observed for other outcomes. Within SKY, changes in HF power and superoxide dismutase (SOD) correlated inversely with changes in MetSSS (r = -0.36, p = 0.039; r = -0.55, p = 0.001). No adverse events occurred. CONCLUSION: 12-week of SKY improved waist circumference, MetS severity, and selected HRV measures in MetS adults. These findings were robust across analyses, while other outcomes were non-significant or inconsistent. Exploratory associations between HRV, SOD, and MetSSS warrant testing in larger, longer-duration trials. TRIAL REGISTRATION: Prospectively registered with the Clinical Trials Registry of India (CTRI/2023/08/056540) on 16-Aug-2023.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Yoga & Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, 560105, India. Electronic address: dilashasethi.ds@gmail.com.
- Division of Yoga & Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, 560105, India. Electronic address: mithila.mv@svyasa.edu.in.
Zitieren
APA
Sethi, D., & Vasudev, M. M. (2026). Effects of a 12-week yogic breathing intervention on metabolic syndrome severity and cardiovascular risk factors: A randomized controlled trial. Complementary Therapies in Medicine, 103, 103447. https://doi.org/10.1016/j.ctim.2026.103447
Vancouver
Sethi D, Vasudev MM. Effects of a 12-week yogic breathing intervention on metabolic syndrome severity and cardiovascular risk factors: A randomized controlled trial. Complementary Therapies in Medicine. 2026;103:103447. doi:10.1016/j.ctim.2026.103447
BibTeX
@article{Sethi2026,
author = {Sethi, Dilasha and Vasudev, Mithila M},
title = {Effects of a 12-week yogic breathing intervention on metabolic syndrome severity and cardiovascular risk factors: A randomized controlled trial},
journal = {Complementary Therapies in Medicine},
year = {2026},
volume = {103},
pages = {103447},
doi = {10.1016/j.ctim.2026.103447}
}
EUVIMED